A detailed history of Nikko Asset Management Americas, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 1,563,065 shares of ARCT stock, worth $28.7 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
1,563,065
Previous 1,276,519 22.45%
Holding current value
$28.7 Million
Previous $43.1 Million 11.71%
% of portfolio
0.44%
Previous 0.43%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$24.35 - $44.39 $6.98 Million - $12.7 Million
286,546 Added 22.45%
1,563,065 $38.1 Million
Q1 2024

May 02, 2024

SELL
$31.23 - $42.99 $1.38 Million - $1.9 Million
-44,133 Reduced 3.34%
1,276,519 $43.1 Million
Q4 2023

Feb 08, 2024

SELL
$17.71 - $32.97 $1.2 Million - $2.24 Million
-67,922 Reduced 4.89%
1,320,652 $41.6 Million
Q3 2023

Nov 09, 2023

SELL
$25.44 - $37.35 $416,147 - $610,971
-16,358 Reduced 1.16%
1,388,574 $35.5 Million
Q2 2023

Aug 14, 2023

SELL
$23.94 - $32.36 $370,327 - $500,576
-15,469 Reduced 1.09%
1,404,932 $40.3 Million
Q1 2023

May 03, 2023

SELL
$14.72 - $23.97 $421,860 - $686,956
-28,659 Reduced 1.98%
1,420,401 $34 Million
Q4 2022

Feb 13, 2023

SELL
$14.14 - $23.06 $146,419 - $238,786
-10,355 Reduced 0.71%
1,449,060 $24.6 Million
Q3 2022

Nov 14, 2022

BUY
$13.05 - $22.13 $303,034 - $513,880
23,221 Added 1.62%
1,459,415 $21.2 Million
Q2 2022

Aug 04, 2022

BUY
$12.26 - $31.17 $418,262 - $1.06 Million
34,116 Added 2.43%
1,436,194 $18 Million
Q1 2022

May 06, 2022

BUY
$17.64 - $39.57 $786,849 - $1.77 Million
44,606 Added 3.29%
1,402,078 $37.9 Million
Q4 2021

Feb 08, 2022

SELL
$34.2 - $47.56 $36,252 - $50,413
-1,060 Reduced 0.08%
1,357,472 $47.8 Million
Q3 2021

Nov 09, 2021

BUY
$27.88 - $58.25 $4 Million - $8.37 Million
143,631 Added 11.82%
1,358,532 $62.5 Million
Q2 2021

Aug 09, 2021

BUY
$25.79 - $42.11 $23.2 Million - $37.9 Million
899,089 Added 284.69%
1,214,901 $41.2 Million
Q1 2021

May 03, 2021

BUY
$38.75 - $86.92 $1.48 Million - $3.31 Million
38,126 Added 13.73%
315,812 $13 Million
Q4 2020

Feb 11, 2021

BUY
$34.61 - $123.66 $5.07 Million - $18.1 Million
146,516 Added 111.7%
277,686 $12 Million
Q3 2020

Nov 02, 2020

SELL
$37.49 - $63.19 $461,764 - $778,311
-12,317 Reduced 8.58%
131,170 $5.63 Million
Q2 2020

Aug 07, 2020

SELL
$12.66 - $58.27 $1.41 Million - $6.5 Million
-111,579 Reduced 43.75%
143,487 $6.56 Million
Q1 2020

Apr 30, 2020

SELL
$9.31 - $18.26 $237,237 - $465,301
-25,482 Reduced 9.08%
255,066 $3.47 Million
Q4 2019

Feb 06, 2020

SELL
$8.93 - $12.41 $160,579 - $223,156
-17,982 Reduced 6.02%
280,548 $3.05 Million
Q3 2019

Oct 29, 2019

BUY
$8.8 - $14.5 $1.48 Million - $2.44 Million
168,556 Added 129.68%
298,530 $3.07 Million
Q2 2019

Jul 29, 2019

BUY
$5.78 - $9.79 $751,249 - $1.27 Million
129,974 New
129,974 $1.23 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $488M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.